Cand.scient. Ana Slipicevic - from Vivi Ann Flørenes's group at the Division of Pathology - will give her trial lecture on the subject "Dysregulation of apoptosis in cancer. An update" on Tuesday May 4th at 15.15.
She will defend her PhD thesis - entitled "Studies of the PI3K/Akt and MAPK/ERK1/2 signaling pathways: identification of novel downstream targets involved in development and progression of melanoma" at 10.15 on Wednesday May 5th.
Venue for both events: Auditorium (BU1), Radiumhospitalet, Montebello, Oslo
From major journals, first or last author from the Institute for Cancer Research
PoDCall: positive droplet calling and normalisation of droplet digital PCR DNA methylation data
Bioinformatics (in press)
Genetic Characterization in High-Risk Individuals from a Low-Resource City of Peru
Cancers (Basel), 14 (22)
Mechanism of CD79A and CD79B Support for IgM+ B Cell Fitness through B Cell Receptor Surface Expression
J Immunol, 209 (10), 2042-2053